Legislation related to anti-microbial resistance generally H.R. 6561 (PREVENT HPV Cancers Act of 2025), all provisions Infectious diseases physician work force issues generally
Literal federal measure citations: H.R. 6561
2025 · 4th Quarter (Oct 1 - Dec 31)
INFECTIOUS DISEASES SOCIETY OF AMERICA
Filed by ARENTFOX SCHIFF LLP.
Open official filingSource-reported fields
Filing overview
- Type
- 4th Quarter - Report
- Posted
- Jan 19, 2026
- Income
- $50,000.00
- Expenses
- Not reported
- Registrant
- ARENTFOX SCHIFF LLP
- Filing UUID
- 5e2e9629-8bff-4e65-9f72-07b7af01fa62
- Termination date
- Not reported
Literal source text
Lobbying issues and bill citations
H.R. 5304 and S. 2587 (Departments of Labor, Health and Human Services, and Education, and Related Agencies Appropriations Act, 2026), Title II, regarding funding for workforce programs, programs dealing with antimicrobial resistance, and programs dealing with infectious diseases generally H.R. 5371 (Continuing Appropriations and Extensions Act, 2026), entire bill H.R. 4445 (Public Health and Bio-Preparedness Workforce Loan Repayment Reauthorization Act of 2025), entire bill
Literal federal measure citations: H.R. 5304, S. 2587, H.R. 5371, H.R. 4445
Medicare reimbursement regarding evaluation and management services by infectious disease physicians, including 2026 Physician Fee Schedule
Relationship and amount limits
Bill links use only the filing year’s mathematically derived Congress plus the literal measure type and number in the issue description. Unmatched citations remain plain text. Politically.com does not join on names, infer advocacy positions, combine amendments, or calculate totals across filings.